iBio, Inc. (IBIO)
Pharmaceutical Preparations
Latest Price
$1.20
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.86
P/B Ratio
1.40
Institutional Ownership
55.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 3.57M | $6.0M | 6.41% | -- | 2026-06-30 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3.52M | $6.0M | 6.32% | +3.29M | 2026-06-30 |
| Vestal Point Capital, LP | 2.60M | $4.0M | 4.67% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.10M | $3.0M | 3.77% | +1.01M | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 1.95M | $3.0M | 3.51% | -- | 2026-06-30 |
| Ensign Peak Advisors, Inc | 1.83M | $3.0M | 3.29% | -- | 2026-06-30 |
| Woodline Partners LP | 1.78M | $3.0M | 3.19% | -- | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 1.65M | $2.0M | 2.97% | +101.6K | 2026-06-30 |
| CITADEL ADVISORS LLC | 1.38M | $2.0M | 2.48% | +427.6K | 2026-06-30 |
| Balyasny Asset Management L.P. | 1.17M | $2.0M | 2.10% | +159.9K | 2026-06-30 |